Cardiovascular diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (i) Patients with suspected hereditary cardiovascular diseases or those with cardiovascular diseases of unknown origin, along with their parents and other relatives. (ii) Patients and others who have consented to the study, including genetic analysis, as detailed in the informed consent or opt-out method. (iii) Patients who have consented to the use of samples or information from the National Cardiovascular Biobank.
Exclusion criteria
Exclusion criteria: (i) Patients who did not consent to the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Exploration of disease-related genes and genetic backgrounds through whole genome and whole exome sequencing analysis. | — |
Countries
Japan
Contacts
National Cerebral and Cardiovascular Center Department of Genomic Medicine